Yale Nobel Laureate Honored with Connecticut Medal of Science
News Apr 22, 2013
Best known for his research into ribosomal proteins, the building blocks of all life, Steitz is also renowned for his work with dozens of student mentees who became scientific leaders, themselves.
Steitz co-founded New Haven-based Rib-X Pharmaceuticals in 2001 to develop new classes of antibiotics. Today, the company has 45 full-time employees.
In addition to the 2009 Nobel Prize in Chemistry, Steitz has received a Gairdner International Award, a Keio Medical Science Prize, the AAAS Newcomb Cleveland Prize, and many other honors.
All in a Droplet: Atomic Resolution of ALS Protein ResolvedNews
Researchers have described atom-by-atom changes in a family of proteins linked to amyotrophic lateral sclerosis (ALS), a group of brain disorders known as frontotemporal dementia and degenerative diseases of muscle and bone.READ MORE
Study Reveals How MRSA Infection Compromises Lymphatic FunctionNews
Infections of the skin or other soft tissues with the hard-to-treat MRSA bacteria appear to permanently compromise the lymphatic system, which is crucial to immune system function. Investigators describe how MRSA infection impairs the ability of lymphatic vessels to pump lymphatic fluid to lymph nodes in mouse models, which may contribute to the frequent recurrences of MRSA infection experienced by patients.